ConforMIS Inc. (NASDAQ:CFMS)’s share price shot up 4% on Thursday . The stock traded as high as $7.38 and last traded at $7.26, with a volume of 138,588 shares changing hands. The stock had previously closed at $6.98.

Several research firms have weighed in on CFMS. Canaccord Genuity reaffirmed a “buy” rating on shares of ConforMIS in a research report on Saturday, May 14th. Oppenheimer Holdings Inc. began coverage on ConforMIS in a research report on Saturday, May 14th. They issued a “buy” rating for the company. Zacks Investment Research raised ConforMIS from a “sell” rating to a “hold” rating in a research report on Friday, July 1st. Deutsche Bank AG dropped their target price on ConforMIS from $26.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, May 13th. Finally, Wells Fargo & Co. downgraded ConforMIS from an “outperform” rating to a “market perform” rating in a research report on Friday, May 13th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $15.20.

The company’s market capitalization is $313.01 million. The company has a 50-day moving average price of $7.12 and a 200 day moving average price of $10.38.

ConforMIS (NASDAQ:CFMS) last posted its quarterly earnings data on Thursday, May 12th. The company reported ($0.37) EPS for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.01. The company had revenue of $20.30 million for the quarter, compared to analyst estimates of $19.23 million. The firm’s quarterly revenue was up 38.1% compared to the same quarter last year. On average, analysts predict that ConforMIS Inc. will post ($1.38) EPS for the current year.

An institutional investor recently raised its position in ConforMIS stock. Wells Fargo & Company MN boosted its position in ConforMIS Inc. (NASDAQ:CFMS) by 38.7% during the fourth quarter, Holdings Channel reports. The firm owned 501,056 shares of the company’s stock after buying an additional 139,708 shares during the period. Wells Fargo & Company MN owned 1.23% of ConforMIS worth $8,663,000 at the end of the most recent quarter.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.